Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced recently that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc. Power3 plans to effectuate the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company in the merger. Rozetta-Cell is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. The company has a robust intellectual property portfolio and has created numerous products for adult stem cell therapy that are ready for market globally. Rozetta-Cell also has several collaborations in process through which it is partnering with industry-leading adult stem cell research companies and adult stem cell vendors.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
American Video Teleconferencing Corp. (Pink Sheets:AVOT) recently announced that it will not be proceeding with the option agreement on the three claim blocks in Northern Saskatchewan as announced on Nov. 29, 2010.
AVOT is also pleased to announce that it has signed an option agreement to acquire two claim blocks in townships of Mekinac and Lajuene, Province of Quebec.
These claim blocks are approximately 3600 acres in total and are located 120 miles east of Montreal P.Q. and 50 miles north of Three Rivers P.Q. They are accessible year round with infrastructure in the immediate vicinity. The claims adjoin a property that had one of the highest readings of Rare Earths in North America. Sampling in the 1950s gave readings of 48% combined Cerium, Lanthanum, Neoymium and Yttrium.
Audiovox Corporation (Nasdaq:VOXX) recently announced that the company received three CEA Innovation Awards from the Consumer Electronics Association. The highly anticipated 2011 Best of Innovations announcements were made at the 2011 International CES press conference, which was attended by elite industry media eager to learn more about this year’s most innovative companies, and their various products coming to market.
Audiovox is a recognized leader in the marketing of automotive entertainment, vehicle security and remote start systems, consumer electronics products and consumer electronics accessories.
Australia Acquisition Corp. (Nasdaq:AACOU) recently announced that it has priced its initial public offering of 6,400,000 units at a price of $10.00 per unit for gross proceeds of $64,000,000. Each unit issued in the initial public offering consists of one ordinary share and one warrant to purchase one ordinary share at an exercise price of $11.50 per ordinary share.
The Company is a newly-formed blank check company organized for the purpose of acquiring or acquiring control of one or more as of yet unidentified operating businesses or assets through a merger, capital stock exchange, asset or stock acquisition, exchangeable share transaction or other similar business transaction.
AXT Inc. (Nasdaq:AXTI) recently announced that it has appointed Liming Zhu, Ph.D. vice president of sales for the Asia region. Zhu previously served as AXT’s vice president of quality and quality systems for the company’s manufacturing facility in Beijing, China. This appointment represents an expansion of AXT’s direct, local sales presence in Asia, marking the increasing strategic importance of this geographic region.
AXT designs, develops, manufactures and distributes high-performance compound and single element semiconductor substrates comprising gallium arsenide (GaAs), indium phosphide (InP) and germanium (Ge) through its manufacturing facilities in Beijing, China.
No comments:
Post a Comment